M&A and Licensing Effects on Trials: Protect Startup Velocity, Preserve Quality, and Stay Audit-Proof
M&A and Licensing Effects on Trials: Protect Startup Velocity, Preserve Quality, and Stay Audit-Proof Keeping Trials Stable Through M&A and Licensing—Speed, Quality, and Audit-Ready Controls What changes when ownership changes: the operating impact of M&A and licensing on active trials Mergers, acquisitions, and asset licensing reshape clinical programs in ways that go far beyond corporate…